CN103159823A - Folic-acid-modified peptide synthesis technique - Google Patents

Folic-acid-modified peptide synthesis technique Download PDF

Info

Publication number
CN103159823A
CN103159823A CN2013101201766A CN201310120176A CN103159823A CN 103159823 A CN103159823 A CN 103159823A CN 2013101201766 A CN2013101201766 A CN 2013101201766A CN 201310120176 A CN201310120176 A CN 201310120176A CN 103159823 A CN103159823 A CN 103159823A
Authority
CN
China
Prior art keywords
polypeptide
dmf
add
resin
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013101201766A
Other languages
Chinese (zh)
Inventor
王锡平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU CHINAPEPTIDES BIOLOGICAL CO Ltd
Original Assignee
SUZHOU CHINAPEPTIDES BIOLOGICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU CHINAPEPTIDES BIOLOGICAL CO Ltd filed Critical SUZHOU CHINAPEPTIDES BIOLOGICAL CO Ltd
Priority to CN2013101201766A priority Critical patent/CN103159823A/en
Publication of CN103159823A publication Critical patent/CN103159823A/en
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a folic-acid-modified peptide synthesis technique, belonging to the field of medicine production. The synthesis technique comprises the following steps: 1) swelling with resin; 2) connecting a first amino acid; 3) deprotecting; 4) detecting; 5) washing; 6) condensing; 7) washing; 8) repeating the operations from the step 2) to the step 6) to sequentially connect amino acids in the sequence from right to left; 9) weighing 5 times of equivalent weight of folic acid, adding into a reaction tube; adding 5 times of equivalent weight of HBTU and 10 times of equivalent weight of DIEA (diisopropylethylamine), reacting for 30 minutes, removing the reaction solution, taking the resin, and carrying out ninhydrin detection; 10) cutting polypeptide from the resin for 120 minutes; 11) blow-drying, and washing; 12) purifying the polypeptide by HPLC (high performance liquid chromatography); 13) freeze-drying the purified solution to obtain the finished product; 14) identification: carrying out molecular weight identification of MS and purity identification by HPLC analysis; and 15) carrying out sealed packaging on the white powdered polypeptide, and storing at -20 DEG C. The invention enhances the success rate in the traditional technique; and since the connection of the polypeptide and folic acid is synchronously completed in the synthesis process, the labor cost is greatly lowered, and the efficiency is greatly enhanced.

Description

Modified with folic acid peptide synthesis technique
Technical field
The present invention relates to a kind of modified with folic acid peptide synthesis technique of medical production field.
Background technology
One of folic acid (Folic acid) vitamin B complex is equivalent to VitB11 (pteroylglutamic acid, PGA), is that Mitchell (H.K.Mitchell, 1941) extracts purifying from the leaf of spinach, so called after folic acid.The effect that promotes juvenile cell maturation in marrow is arranged, can cause megaloblastic anemia and leukopenia if the mankind lack folic acid, the pregnant woman is even more important.Peptide is that a-amino acid links together with peptide chain and the compound that forms, and it is also the intermediate product of proteolysis.The compound that is formed by two amino acid molecular dehydrating condensations is called dipeptides, in like manner analogizes tripeptides, tetrapeptide, pentapeptide etc. in addition.Usually the compound that is formed by 10 ~ 100 amino acid molecular dehydrating condensations is polypeptide.Their molecular weight is lower than 10,000Da(Dalton dalton), can see through semi-permeable membranes, do not precipitated by trichoroacetic acid(TCA) and ammonium sulfate.Also there is document that the peptide that is comprised of 2 ~ 10 amino acid is called oligopeptides (small-molecular peptides); The peptide of 10 ~ 50 amino acid compositions is called polypeptide; The peptide that is comprised of the amino acid more than 50 just is called protein.At present the research about the functional aspect of the combination of folic acid and polypeptide is a focus direction.But the method to the coupling of folic acid and polypeptide on market still is in the junior stage, and technique of the present invention is to have made optimization on forefathers' Research foundation.Can effectively improve the success ratio of coupling and reach yield, reducing synthetic cost.
Summary of the invention
The objective of the invention is to overcome the deficiencies in the prior art, optimize existing technical process, a kind of success ratio that can effectively improve coupling, and yield and reduce the modified with folic acid peptide new synthetic process of synthetic cost are provided.
The present invention is achieved by the following technical solutions:
A kind of modified with folic acid peptide synthesis technique, its synthesis technique step is as follows:
1) resin swelling
2-Chlorotrityl Chloride Resin resin is put into reaction tubes, add DCM (15ml/g), vibration 30min;
2) connect first amino acid
Fall solvent by husky core suction filtration, add the Fmoc-L-Pro-OH amino acid of 3 times of molar excess, then add the DIEA of 10 times of molar excess, add at last the DMF dissolving, vibration 30min;
3) deprotection
Remove DMF, add 20% piperidines DMF solution (15ml/g), 5min removes and adds 20% piperidines DMF solution (15ml/g), 15min again;
4) detect
Take out piperidine solution, get tens grainy resins, wash three times with ethanol, add triketohydrindene hydrate, KCN, each of phenol solution, 105 ℃-110 ℃ heating 5min deepen blue positive reaction;
5) wash
DMF (10ml/g) twice, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g);
6) condensation
Method a: three times of protected amino acids (FmocAAA-OH) are excessive, and three times of HBTU are excessive, all with DMF dissolving less as far as possible, add reaction tubes, add at once ten times of NMM excessive. reaction 30min;
7) wash DMF (10ml/g) once, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g); 8) repeat the operation of two to seven steps, from right to left the amino acid in catenation sequence successively;
9) 5 times of equivalent folic acid of weighing, join in reaction tubes, then adds the HBTU of 5 times of equivalents, the DIEA of 10 times of equivalents, and reaction 30min had both taken out reaction solution, got resin and carried out the triketohydrindene hydrate detection;
10) cut polypeptide from resin
Preparation cutting liquid (10/g) TFA 94.5%; Water 2.5%; EDT 2.5%; TIS 1%;
Clipping time: 120min;
11) dry up washing
Lysate is dried up with nitrogen as far as possible, wash six times with ether, then normal temperature volatilizes;
12) use the HPLC purified polypeptide;
13) at last with the solution freeze-drying after purifying, both obtained finished product;
14) identify
The finished product polypeptide that takes a morsel is respectively done the molecular weight identification of MS, and the Purity analyzed of HPLC;
15) with the polypeptide of white powder, pack-20 ℃ of preservations.
The present invention compared with prior art has following beneficial effect:
1. improve the success ratio of coupling and reach yield;
2. reduce synthetic cost.
Embodiment
Below in conjunction with embodiment, content of the present invention is described in further detail:
technique of the present invention is on the basis of the solid phase synthesis of polypeptide, utilize the synthetic advantage of Solid-phase Polypeptide, practical situation in conjunction with folic acid, and a kind of modified with folic acid peptide synthesis technique that proposes, at first be the polypeptide portion sequence of definite folic acid peptide that will synthesize, then the method according to solid phase synthesis is synthesized polypeptide, but first not cracking, only out get final product the end NH2 of polypeptide is exposed, then according to the actual molar equivalent of polypeptide, ratio with folic acid: polypeptide=5:1 drops into reaction with folic acid, then can detect very easily with triketohydrindene hydrate--whether NH2 exists can judge whether reaction is complete.This technique has improved the upper success ratio of traditional technology greatly, and also owing to being that polypeptide is connected connection and is synchronously completed in synthetic with folic acid, old friend's work cost has also reduced greatly, and efficient is greatly improved.
Be below synthesis material and related reagent:
1) protected amino acid raw material
Fmoc-AAA-OH, folic acid
2) condensation reagent
HBTU,DIEA
3) solvent
DMF, DCM, acetonitrile
4) resin
2-Chlorotrityl?Chloride?Resin
5) deprotecting regent
Piperidines
6) cutting reagent
TFA,TIS,EDT?,H2O
7) nitrogen
8) anhydrous diethyl ether
9) precise electronic balance
The synthesis technique step is as follows:
1) resin swelling
2-Chlorotrityl Chloride Resin resin is put into reaction tubes, add DCM (15ml/g), vibration 30min;
2) connect first amino acid
Fall solvent by husky core suction filtration, add the Fmoc-L-Pro-OH amino acid of 3 times of molar excess, then add the DIEA of 10 times of molar excess, add at last the DMF dissolving, vibration 30min;
3) deprotection
Remove DMF, add 20% piperidines DMF solution (15ml/g), 5min removes and adds 20% piperidines DMF solution (15ml/g), 15min again;
4) detect
Take out piperidine solution, get tens grainy resins, wash three times with ethanol, add triketohydrindene hydrate, KCN, each of phenol solution, 105 ℃-110 ℃ heating 5min deepen blue positive reaction;
5) wash
DMF (10ml/g) twice, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g)
6) condensation
Method a: three times of protected amino acids (FmocAAA-OH) are excessive, and three times of HBTU are excessive, all with DMF dissolving less as far as possible, add reaction tubes, add at once ten times of NMM excessive. reaction 30min;
7) wash
DMF (10ml/g) once, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g); 8) repeat the operation of two to seven steps, from right to left the amino acid in catenation sequence successively;
9) 5 times of equivalent folic acid of weighing, join in reaction tubes, then adds the HBTU of 5 times of equivalents, the DIEA of 10 times of equivalents, and reaction 30min had both taken out reaction solution, got resin and carried out the triketohydrindene hydrate detection;
10) cut polypeptide from resin
Preparation cutting liquid (10/g) TFA 94.5%; Water 2.5%; EDT 2.5%; TIS 1%;
Clipping time: 120min;
11) dry up washing
Lysate is dried up with nitrogen as far as possible, wash six times with ether, then normal temperature volatilizes;
12) use the HPLC purified polypeptide;
13) at last with the solution freeze-drying after purifying, both obtained finished product;
14) identify
The finished product polypeptide that takes a morsel is respectively done the molecular weight identification of MS, and the Purity analyzed of HPLC;
15) with the polypeptide of white powder, pack-20 ℃ of preservations.

Claims (1)

1. modified with folic acid peptide synthesis technique, it is characterized in that: the synthesis technique step is as follows:
1) resin swelling
2-Chlorotrityl Chloride Resin resin is put into reaction tubes, add DCM (15ml/g), vibration 30min;
2) connect first amino acid
Fall solvent by husky core suction filtration, add the Fmoc-L-Pro-OH amino acid of 3 times of molar excess, then add the DIEA of 10 times of molar excess, add at last the DMF dissolving, vibration 30min;
3) deprotection
Remove DMF, add 20% piperidines DMF solution (15ml/g), 5min removes and adds 20% piperidines DMF solution (15ml/g), 15min again;
4) detect
Take out piperidine solution, get tens grainy resins, wash three times with ethanol, add triketohydrindene hydrate, KCN, each of phenol solution, 105 ℃-110 ℃ heating 5min deepen blue positive reaction;
5) wash
DMF (10ml/g) twice, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g);
6) condensation
Method a: three times of protected amino acids (FmocAAA-OH) are excessive, and three times of HBTU are excessive, all with DMF dissolving less as far as possible, add reaction tubes, add at once ten times of NMM excessive. reaction 30min;
7) wash
DMF (10ml/g) once, methyl alcohol (10ml/g) twice, twice of DMF (10ml/g); 8) repeat the operation of two to seven steps, from right to left the amino acid in catenation sequence successively;
9) 5 times of equivalent folic acid of weighing, join in reaction tubes, then adds the HBTU of 5 times of equivalents, the DIEA of 10 times of equivalents, and reaction 30min had both taken out reaction solution, got resin and carried out the triketohydrindene hydrate detection;
10) cut polypeptide from resin
Preparation cutting liquid (10/g) TFA 94.5%, water 2.5%, EDT 2.5%, and TIS 1%;
Clipping time: 120min;
11) dry up washing
Lysate is dried up with nitrogen as far as possible, wash six times with ether, then normal temperature volatilizes;
12) use the HPLC purified polypeptide;
13) at last with the solution freeze-drying after purifying, both obtained finished product;
14) identify
The finished product polypeptide that takes a morsel is respectively done the molecular weight identification of MS, and the Purity analyzed of HPLC;
15) with the polypeptide of white powder, pack-20 ℃ of preservations.
CN2013101201766A 2013-04-09 2013-04-09 Folic-acid-modified peptide synthesis technique Pending CN103159823A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013101201766A CN103159823A (en) 2013-04-09 2013-04-09 Folic-acid-modified peptide synthesis technique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013101201766A CN103159823A (en) 2013-04-09 2013-04-09 Folic-acid-modified peptide synthesis technique

Publications (1)

Publication Number Publication Date
CN103159823A true CN103159823A (en) 2013-06-19

Family

ID=48583387

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013101201766A Pending CN103159823A (en) 2013-04-09 2013-04-09 Folic-acid-modified peptide synthesis technique

Country Status (1)

Country Link
CN (1) CN103159823A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111269291A (en) * 2020-03-20 2020-06-12 三峡大学 Oligopeptide synthesis and application of oligopeptide in medicine for inhibiting citrus saprogenicia citrobacter fingerlike penicillium
CN113384715A (en) * 2021-06-03 2021-09-14 上海市第十人民医院 anti-VEGF (vascular endothelial growth factor) medicine containing cell penetrating peptide fusion protein as well as preparation method and application of anti-VEGF medicine
CN114591391A (en) * 2022-03-22 2022-06-07 湖北强耀生物科技有限公司 Synthesis process of O-sugar peptide bond polypeptide
CN114634425A (en) * 2022-03-22 2022-06-17 湖北强耀生物科技有限公司 Novel synthesis process of PSMA inhibitor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7038037B2 (en) * 2002-06-20 2006-05-02 Isis Pharmaceuticals, Inc. Method for sequential support-bound synthesis of conjugated oligomeric compounds
CN101224306A (en) * 2008-02-20 2008-07-23 中山大学 Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof
CN102120756A (en) * 2010-12-07 2011-07-13 南开大学 Taxol-based small molecule hydrogel-nanosphere transmission system and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7038037B2 (en) * 2002-06-20 2006-05-02 Isis Pharmaceuticals, Inc. Method for sequential support-bound synthesis of conjugated oligomeric compounds
CN101224306A (en) * 2008-02-20 2008-07-23 中山大学 Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof
CN102120756A (en) * 2010-12-07 2011-07-13 南开大学 Taxol-based small molecule hydrogel-nanosphere transmission system and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111269291A (en) * 2020-03-20 2020-06-12 三峡大学 Oligopeptide synthesis and application of oligopeptide in medicine for inhibiting citrus saprogenicia citrobacter fingerlike penicillium
CN111269291B (en) * 2020-03-20 2023-11-21 三峡大学 Synthesis of oligopeptide and application of oligopeptide in medicines for inhibiting citrus saprophytic bacteria penicillium digitatum
CN113384715A (en) * 2021-06-03 2021-09-14 上海市第十人民医院 anti-VEGF (vascular endothelial growth factor) medicine containing cell penetrating peptide fusion protein as well as preparation method and application of anti-VEGF medicine
CN113384715B (en) * 2021-06-03 2023-08-04 上海市第十人民医院 anti-VEGF medicine containing cell penetrating peptide fusion protein, and preparation method and application thereof
CN114591391A (en) * 2022-03-22 2022-06-07 湖北强耀生物科技有限公司 Synthesis process of O-sugar peptide bond polypeptide
CN114634425A (en) * 2022-03-22 2022-06-17 湖北强耀生物科技有限公司 Novel synthesis process of PSMA inhibitor

Similar Documents

Publication Publication Date Title
CN103159823A (en) Folic-acid-modified peptide synthesis technique
CN101693738B (en) Method for synthesizing terlipressin by solid-phase oxidization and cyclization
CN103087152B (en) Extraction process of oxytocin solution
CN102603869B (en) Synthetic method of hexapeptide
CN102286589B (en) The preparation method of turtle oligopeptide
CN107573408A (en) A kind of synthetic method of high-purity Leuprorelin
CN104592362A (en) Synthesis process of carbetocin
CN101838308B (en) Solid-phase synthesis method for eptifibatide
CN105504012A (en) Preparation method of polypeptide
CN104926920A (en) Protein polypeptide drug N-terminal fixed-point polyethylene glycol modification method
CN105418736A (en) Preparation method of terlipressin through combination of solid and liquid
CN103880945A (en) Method for preparing high-purity thymalfasin
CN102286588B (en) Method for preparing turtle peptide
CN103992390A (en) Carbetocin synthesis method
CN109438551B (en) Method for concentrating trace protein sample
CN107056894A (en) A kind of method of fragment method synthesis in solid state ganirelix acetate
CN109053863A (en) A kind of method of low cost preparation high-purity Linaclotide
CN105384799A (en) Method for preparing sinapultide by combining solid phase and liquid phase
CN104277097B (en) Method for preparing synthetic peptide antigen 2700 of swine O-type foot and mouth disease through solid-phase fragment process
CN103351426A (en) Polypeptide synthesis method for octreotide acetate
CN110627875A (en) Mitochondrion targeting membrane-penetrating cyclopeptide and preparation method and application thereof
CN109535162A (en) A kind of preparation method of N- p-benzoyl glutamy folic acid
CN102212191B (en) Amine-terminated polyether and continuous preparation method thereof
CN104017058A (en) Method for preparing ganirelix acetate
CN113912673A (en) Low-bitter ACE inhibitory peptide derived from sesame, and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130619